| 注册
首页|期刊导航|浙江医学|G-HAA 方案治疗难治、复发性急性髓系白血病的疗效观察

G-HAA 方案治疗难治、复发性急性髓系白血病的疗效观察

李双月 曹俊杰 庄贤栩 吴静怡 范峥 林丽 叶佩佩 唐善浩 张碧波 史晓薇 裴仁治 张丕胜 刘旭辉 马俊霞 杜小红 陈冬 沙科娅 陈列光

浙江医学Issue(2):105-107,110,4.
浙江医学Issue(2):105-107,110,4.

G-HAA 方案治疗难治、复发性急性髓系白血病的疗效观察

Efficacy and safety of G-HAA regimen in treatment of refractory and relapsing acute myeloid leukemia

李双月 1曹俊杰 1庄贤栩 1吴静怡 1范峥 1林丽 1叶佩佩 1唐善浩 1张碧波 1史晓薇 1裴仁治 1张丕胜 1刘旭辉 1马俊霞 1杜小红 1陈冬 1沙科娅 1陈列光1

作者信息

  • 1. 315040 宁波,鄞州人民医院血液科
  • 折叠

摘要

Abstract

Objective To evaluate the efficacy and safety of G-HAA regimen consisting of low dose cytosine arabinoside (Ara-C), aclacinomycin (ACR), homoharringtonine (HHT) and granulocyte colony stimulating factor (G-CSF) in treatment of re-fractory and relapsing acute myeloid leukemia (AML). Methods Forty eight patients with refractory and relapsing AML, admitted from March 2008 to February 2012, were randomly assigned to CAG regimen (Ara-C, aclarubicin with G-CSF) and G-HAA regi-men. The two groups were further divided into three subgroups: children group (≤14y), young and middle-aged group (15 to 59y) and elderly group (≥60y) . The efficacy and side effects were analyzed and compared between the groups. Results The total complete remission (CR) rates in CAG group and G-HAA group were 69.6% and 76.0%, respectively (P >0.05) ; the overal effective rates (CR+PR) were 87.0% and 92.0%, respectively (P >0.05). The CR rates for M4、M5 subtype were 44.4% and 90.9%, in two groups respectively (P<0.05); but there was no difference in CR rates for M1、M2 subtype and MDS transformation. In chil-dren group, the CR rate treated with CAG regimen and G-HAA regimen were 37.5% and 90.0% respectively (P<0.05) , but there were no differences in the other two age groups. Further analysis of the children's group demonstrated that the CR rates for M4、M5 subtype of CAG regimen and G-HAA regimen were 20.0% and 100.0% respectively (P<0.05); but there were no differences in M1、M2 subtype. There were no significant differences in side effects among the groups. Conclusion The results indicate that the G-HAA regimen has the same efficacy and safety as CAG regimen in treatment of refractory and relapsing AML, however G-HAA regimen might be more effective in M4、M5 subtype, particularly in child patients.

关键词

G-HAA方案/难治性/复发性/急性髓系白血病

Key words

G-HAA regimen/Refractory/Relapse/Acute myeloid leukemia

引用本文复制引用

李双月,曹俊杰,庄贤栩,吴静怡,范峥,林丽,叶佩佩,唐善浩,张碧波,史晓薇,裴仁治,张丕胜,刘旭辉,马俊霞,杜小红,陈冬,沙科娅,陈列光..G-HAA 方案治疗难治、复发性急性髓系白血病的疗效观察[J].浙江医学,2013,(2):105-107,110,4.

浙江医学

OACSTPCD

1006-2785

访问量7
|
下载量0
段落导航相关论文